Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, Arora M, Jagasia M, Vogelsang GB, Lee SJ
Biol Blood Marrow Transplant. 2014 20 (3): 337-44

PMID: 24315845 · PMCID: PMC3973401 · DOI:10.1016/j.bbmt.2013.11.025

MeSH Terms (22)

Adolescent Adult Child Child, Preschool Chronic Disease Female Graft vs Host Disease Hematologic Neoplasms Hematopoietic Stem Cell Transplantation Humans Lung Male National Institutes of Health (U.S.) Patient Outcome Assessment Proportional Hazards Models Prospective Studies Research Design Respiratory Function Tests Severity of Illness Index Survival Analysis Transplantation, Homologous United States

Connections (1)

This publication is referenced by other Labnodes entities: